In AD, along with amyloid and tau phosphorylation, there is an associated increase in inflammation/glial activation, a decrease in synaptic function, an increase in astrocyte activation, and a state of insulin resistance
A comprehensive meta-analysis published in 2017 examining data from over 60,000 patients found no significant increase in pancreatic cancer risk associated with GLP-1 receptor agonist use
The hormonal adaptation pattern that drives regain is a 12-month story, not a transient
Researchers use Semaglutide when studying isolated GLP-1R pharmacology, and Retatrutide when studying the combined tri-receptor incretin system, energy expenditure mechanisms, and the full scope of multi-pathway metabolic regulation
Oral agents like phentermine or topiramate improve early satiety and help control the drive to snack between meals
Whether partial engagement produces durable metabolic change remains uncertain